Systemic Distribution of Somatostatin Receptor Subtypes in Human: An Immunohistochemical Study
Authors:
Open Access
- 1 January 2005
- journal article
- Published by Japan Endocrine Society in Endocrine Journal
- Vol. 52 (5) , 605-611
Abstract
Somatostatin is well known to inhibit the hormone secretion of various peptides. This action has been considered to be generally mediated via six different specific somatostatin receptors (sstr), sstr1, sstr2A, sstr2B, sstr3, sstr4, and sstr5. It then becomes very important to demonstrate the localization of these sstr subtypes in order to elucidate the possible biological and/or clinical significance of somatostatin actions. These sstr subtypes have been demonstrated to be expressed throughout the human body, including the central nervous system, gastrointestinal tract, pancreas, kidney, and other organs, but its details, especially its systemic distribution and localization in tissue compartments, have yet to be examined thoroughly in human. Therefore, in this study, we examined the systemic localization of all six somatostatin receptors in normal human organs using immunohistochemistry with recently developed specific antibodies against these receptor subtypes. In all of the human tissues examined, various sstr subtypes were detected not only in parenchymal cells but also in various stromal cells such as lymphocytes, fibroblasts, and endothelial cells. Among human tissues in which the presence of sstr has not been previously reported, the parotid gland demonstrated immunoreactivity for sstr2B and sstr5, bronchial gland for sstr1, 2B, 3, 4, 5, parathyroid gland for sstr1, 3, 4, and duodenum for all subtypes immunoreactivity. The great majority of other organs examined demonstrated results consistent with those of previously reported biochemical studies. In pancreatic islet cells, only sstr2A was positive in all the cases but other sstr subtypes were associated with marked intraislet heterogeneity in their distribution. In stomach, all subtypes of receptor were detected in various cell types of the mucosa, but none in ECL cells of fundic gland. These findings demonstrated the broad systemic actions of somatostatin in non-endocrine cells.Keywords
This publication has 32 references indexed in Scilit:
- Somatostatin regulates intracellular signaling in human carotid endothelial cellsBiochemical and Biophysical Research Communications, 2004
- Extensive hemorrhagic erosive gastritis associated with acute pancreatitis successfully treated with a somatostatin analogJournal of Gastroenterology, 2002
- Huan normal dermal fibroblasts express somatostain receptorsExperimental Dermatology, 1999
- Somatostatin and Its Receptor FamilyFrontiers in Neuroendocrinology, 1999
- Somatostatin receptor subtype 2 mediates inhibition of gastrin and histamine secretion from human, dog, and rat antrumGastroenterology, 1996
- Octreotide in the management of treatment-related diarrhoeaAnti-Cancer Drugs, 1996
- Expression of mRNA for all five human somatostatin receptors (hSSTR1-5) in pituitary tumorsLife Sciences, 1994
- Somatostatin and primary hyperparathyroidismBritish Journal of Surgery, 1994
- Multiple Gene Transcripts of the Somatostatin Receptor SSTR2: Tissue-Selective Distribution and cAMP RegulationBiochemical and Biophysical Research Communications, 1993
- Effects of a long-acting somatostatin analogue in patients with severe ileostomy diarrhoeaBritish Journal of Surgery, 1986